GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Boundless Bio Inc (NAS:BOLD) » Definitions » Net Interest Margin (Bank Only) %

Boundless Bio (Boundless Bio) Net Interest Margin (Bank Only) %


View and export this data going back to 2024. Start your Free Trial

What is Boundless Bio Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.


Boundless Bio (Boundless Bio) Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.